Analysis of lung adenocarcinoma in patients aged 70 and over: The viewpoint of clinical stage, therapeutic modality and prognosis

M. Matsumoto, E. Moriyama, I. Okamoto (Kumamoto, Japan)

Source: Annual Congress 2002 - Lung cancer: clinical characteristics and prognosis
Session: Lung cancer: clinical characteristics and prognosis
Session type: Thematic Poster Session
Number: 1724
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Matsumoto, E. Moriyama, I. Okamoto (Kumamoto, Japan). Analysis of lung adenocarcinoma in patients aged 70 and over: The viewpoint of clinical stage, therapeutic modality and prognosis. Eur Respir J 2002; 20: Suppl. 38, 1724

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical characteristics, treatment, and prognosis of lung cancer elderly patients
Source: Eur Respir J 2001; 18: Suppl. 33, 228s
Year: 2001

Therapeutic approach in patients above 65 years with lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 303s
Year: 2004

Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011


Clinical features of lung cancer cases: a fifteen years experience
Source: Eur Respir J 2004; 24: Suppl. 48, 300s
Year: 2004

Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 disease
Source: Eur Respir J, 51 (4) 1800410; 10.1183/13993003.00410-2018
Year: 2018



Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 disease
Source: Eur Respir J, 51 (4) 1800084; 10.1183/13993003.00084-2018
Year: 2018



Clinical trials in advanced stage lung cancer: A survey of patients‘ opinion about their treatment
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010

Clinical feature of elderly patients with lung cancer
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008

A new WHO classification for lung cancer after 11 years: clinical implications
Source: International Congress 2015 – Lung cancer pathology
Year: 2015



Analysis of the clinical feature of 383 patients with lung cancer
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011

Clinical course of asymptomatic small enhancing brain nodules in patients with nonsmall cell lung cancer: do we have to follow them up?
Source: ERJ Open Res, 6 (3) 00109-2020; 10.1183/23120541.00109-2020
Year: 2020



Main reasons for a low accrual pattern in clinical trials of patients with advanced stage non-small cell lung cancer (NSCLC)
Source: Annual Congress 2008 - Influence of teaching models on skills and knowledge of medical doctors
Year: 2008


Curative treatment vs. best supportive care in advanced non small cell lung cancer in aged person
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011

Clinical, histological and molecular characteristics of lung cancer in patients under 30 years-old.
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018



Characteristics of lung cancer patients in Serbia and subsequent treatment in advanced NSCLC over time – epidemiology study
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017

Clinical outcome of Pembrolizumab (PEMB) monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC) – Reports from routine clinical care.
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019

Emergency presentation of lung cancer patients via A&E increases the chances of having advanced disease stage and worse performance status
Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders
Year: 2017

Time lost for diagnostics of lung carcinoma related to disease stage and prognosis
Source: Eur Respir J 2004; 24: Suppl. 48, 297s
Year: 2004

A preliminary comprehensive hormonal evaluation on a prospective group of patients (pts) with advanced lung cancer
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009

Comparative evaluation of survival time between women and men with advanced lung cancer
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008